Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Increasing Cardiac Rehabilitation Attendance After a Secondary MI

Official title: Activating Teams and Patients to Enhance Attendance at Cardiac Rehabilitation After Secondary Myocardial Infarction (ATTEND-CR) Trial

Run by Massachusetts General Hospital · NCT07485491 · Data updated 2026-11-12

This trial tests whether a clinician message + a patient phone call can help adults with a secondary/type 2 MI attend more cardiac rehabilitation sessions.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 2026
Main results expectedApril 2028
Study endsApril 2028
Registry record updatedSeptember 23, 2026
Trial IDNCT07485491 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older hospitalized with secondary/type 2 MI who have a Mass General Brigham PCP and can participate in CR after discharge.

Probably not a fit

Patients who do not attend or complete CR despite the intervention or have contraindications to CR participation may see little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center pilot randomized trial evaluates a low-risk behavioral intervention aimed at improving participation in cardiac rehabilitation after a secondary/type 2 myocardial infarction. Participants are randomized to receive clinician-focused messaging about referral and a motivational interviewing call to the patient, or usual care. Follow-up for 140 days includes remote check-ins and electronic health record review to measure attendance, clinical events, medication use, and patient-reported health status. Safety monitoring is ongoing to detect any adverse events related to the intervention. The study focuses on whether increased engagement with CR can translate into higher attendance and completion rates.

Why it matters

Potential benefit: If successful, the intervention could improve CR participation, potentially enhancing functional outcomes and quality of life for patients after secondary/type 2 MI.

How similar studies have gone: Prior similar behavioral approaches have shown promise in increasing CR engagement, though this exact clinician-patient messaging combination is being tested in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Inpatient at MGH with an index likely or confirmed secondary MI
* Primary care provider (PCP) within the Mass General Brigham (MGB) network with at least one visit in the past 2 years
* Anticipated ability to ambulate independently without walking aids or supplemental ambulatory oxygen at discharge
* Ability to provide informed consent

Exclusion Criteria:

* Known severe untreated valvular heart disease or severe prosthetic valve dysfunction
* Known hypertrophic obstructive cardiomyopathy
* End-stage heart failure (VAD, transplant patient, or undergoing evaluation for VAD or transplant)
* Hemodynamic instability at the time of pre-screening
* Terminal illness with life expectancy \< 1 year
* Severe anemia (hemoglobin \< 8 g/dL) at the time of pre-screening
* Active, unstable cancer (excluding non-metastatic skin cancer) or currently receiving intensive cancer therapy
* Advanced kidney disease requiring renal replacement therapy
* Receiving palliative or comfort care only
* Recurrent falls (≥2) or falls with injury in the past year
* Physical or cognitive impairment likely to prevent safe participation in exercise over the next 5 months (e.g., significant stroke deficits, dementia)
* High-risk for non-adherence to study requirements
* Incarcerated individuals
* Currently pregnant or within 3 months postpartum
* Previously referred to or participated in CR within the past year
* Alternative MI subtype (spontaneous \[type 1 MI\] or procedural MI \[type 4 or 5 MI\]) in the past 6 months
* Suspected or confirmed coronary mechanism of index MI (vasospasm, embolism, or spontaneous coronary artery dissection)
* Anticipated discharge or discharged before enrollment measures can be completed
* Anticipated discharge to a facility where independent participation in CR is not feasible
* Previously enrolled in or declined participation in this study

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Cian P McCarthy, MB, BCh, BAO, SM — Massachusetts General Hospital
  • Study coordinator: Cian McCarthy, MB, BCh, BAO, SM
  • Email: CMCCARTHY37@MGB.ORG
  • Phone: 617-726-2000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.